Skip to main content
Research

Publications: Dr Ruth Dobson

Dobson R ( 2022 ) . Social determinants of health and their impact in multiple sclerosis . Nature Reviews Neurology
Simpson-Yap S, Pirmani A, Kalincik T, De Brouwer E, Geys L, Parciak T, Helme A, Rijke N et al. ( 2022 ) . Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity . Neurology(R) neuroimmunology & neuroinflammation vol. 9 , ( 6 )
Dobson R, Bove R ( 2022 ) . In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk . Neurology vol. 99 , ( 17 ) 737 - 738 .
Dobson R, Bove R ( 2022 ) . In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk . Neurology vol. 99 , ( 17 ) 737 - 738 .
Simpson-Yap S, Pirmani A, De Brouwer E, Peeters LM, Geys L, Parciak T, Helme A, Hillert J et al. ( 2022 ) . Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β . Multiple Sclerosis and Related Disorders vol. 66 ,
Jacobs BM, Peter M, Giovannoni G, Noyce AJ, Morris HR, Dobson R ( 2022 ) . Towards a global view of multiple sclerosis genetics . Nature Reviews Neurology vol. 18 , ( 10 ) 613 - 623 .
Hone L, Jacobs BM, Marshall C, Giovannoni G, Noyce A, Dobson R ( 2022 ) . Age-specific effects of childhood body mass index on multiple sclerosis risk . Journal of Neurology vol. 269 , ( 9 ) 5052 - 5060 .
Allen-Philbey K, Stennett A, Begum T, Johnson AC, MacDougall A, Green S, Dobson R, Giovannoni G et al. ( 2022 ) . Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 65 ,
Foote IF, Jacobs BM, Mathlin G, Watson CJ, Bothongo PL, Waters S, Dobson R, Noyce AJ et al. ( 2022 ) . The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study . Neurobiology of Aging vol. 117 , 222 - 235 .
Bove R, Hellwig K, Pasquarelli N, Borriello F, Dobson R, Oreja-Guevara C, Lin CJ, Zecevic D et al. ( 2022 ) . Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants . Multiple Sclerosis and Related Disorders vol. 64 ,
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al. ( 2022 ) . Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 64 ,
Tur C, Dubessy AL, Otero-Romero S, Amato MP, Derfuss T, Di Pauli F, Iacobaeus E, Mycko M et al. ( 2022 ) . The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021 . Multiple Sclerosis Journal vol. 28 , ( 9 ) 1424 - 1456 .
Dobson R, Tanasescu R, Gran B ( 2022 ) . Editorial: Preventing multiple sclerosis . Frontiers in Neurology vol. 13 ,
Dobson R ( 2022 ) . Preventing Multiple Sclerosis - from evidence to action . Frontiers in Neurology
Rivas C, Anand K, Wu AFW, Goff L, Dobson R, Eccles J, Ball E, Kumar S et al. ( 2022 ) . Lessons From the COVID-19 Pandemic to Improve the Health, Social Care, and Well-being of Minoritized Ethnic Groups With Chronic Conditions or Impairments: Protocol for a Mixed Methods Study . JMIR Research Protocols vol. 11 , ( 7 )
Judge-Clayden F, Iyer P, Williams A, Murray K, Dobson R ( 2022 ) . Multiple sclerosis, disease modifying therapies and pregnancy . British Journal of Neuroscience Nursing vol. 18 , ( Sup3 ) s22 - s26 .
Jensen M, Jacobs B, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Noyce A ( 2022 ) . Lower lymphocyte count is associated with increased risk of Parkinson’s disease . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a94.3 - a9a95 .
Belete D, Jacobs BM, Bestwick JP, Dobson R, Hardy J, Giovannoni G, Lees A, Schrag A et al. ( 2022 ) . Parkinson’s disease determinants, prediction and gene-environment interac- tions: a UK Biobank study . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a7.3 - a7a8 .
Dobson R ( 2022 ) . Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS) . Multiple Sclerosis and Related Disorders
Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R ( 2022 ) . Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals? . Clin Exp Immunol vol. 207 , ( 3 ) 263 - 271 .
Simonet C, Bestwick J, Jitlal M, Waters S, Ben-Joseph A, Marshall CR, Dobson R, Marrium S et al. ( 2022 ) . Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population . JAMA Neurology vol. 79 , ( 4 ) 359 - 369 .
Marshall CR, Noyce AJ, Neligan A, Dobson R ( 2022 ) . Brain health: The hidden casualty of a humanitarian crisis . The Lancet Regional Health - Europe vol. 15 ,
Bothongo PLK, Jitlal M, Parry E, Waters S, Foote IF, Watson CJ, Cuzick J, Giovannoni G et al. ( 2022 ) . Dementia risk in a diverse population: A single-region nested case-control study in the East End of London . The Lancet Regional Health - Europe vol. 15 ,
Vukusic S, Dobson R, Bove RM, Hellwig K, Pasquarelli N, Zecevic D, Oreja-Guevara C ( 2022 ) . Données de grossesses chez des femmes recevant de l’ocrelizumab pour le traitement de la sclérose en plaques . Revue Neurologique vol. 178 ,
Dobson R ( 2022 ) . Peripartum disease activity in moderately and severely disabled women with multiple sclerosis . Multiple Sclerosis Journal - Experimental, Translational and Clinical
Dobson R ( 2022 ) . Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study . Frontiers in Neurology
Noyce A ( 2022 ) . No evidence for association between polygenic risk of Multiple Sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants . Multiple Sclerosis Journal
Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R ( 2022 ) . Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals? . Clinical and Experimental Immunology vol. 207 , ( 3 ) 263 - 271 .
Hone L, Giovannoni G, Dobson R, Jacobs BM ( 2022 ) . Predicting Multiple Sclerosis: Challenges and Opportunities . Frontiers in Neurology vol. 12 ,
Dobson R, Chung K ( 2022 ) . Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary . Multiple Sclerosis Journal vol. 28 , ( 2 ) 326 - 327 .
Huxford B, Haque T, Joseph AB, Simonet C, Gallagher D, Budu C, Dobson R, Noyce AJ ( 2022 ) . Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity . Movement Disorders vol. 37 , ( 2 ) 427 - 428 .
Dobson R, Marshall C, Noyce A ( 2022 ) . Social determinants of neurological disease: tackling inequalities . The Lancet Neurology vol. 21 , ( 2 ) 122 - 123 .
Satukijchai C, Mariano R, Messina S, Sa M, Woodhall MR, Robertson NP, Ming L, Wassmer E et al. ( 2022 ) . Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom . JAMA Netw Open vol. 5 , ( 1 )
Dobson R, Rog D, Ovadia C, Murray K, Hughes S, Ford HL, Pearson OR, White S et al. ( 2022 ) . Anti-CD20 therapies in pregnancy and breast feeding: A review and ABN guidelines . Practical Neurology
Camera V, Messina S, Elhadd KT, Sanpera-Iglesias J, Mariano R, Hacohen Y, Dobson R, Meletti S et al. ( 2022 ) . Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders . Journal of neurology, neurosurgery, and psychiatry vol. 93 , ( 1 ) 101 - 111 .
Kuri A, Vickaryous N, Awad A, Jacobs BM, Dobson R ( 2022 ) . Vitamin D genetic risk scores in multiple sclerosis . Journal of Neurology
Baker D ( 2021 ) . CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis . Multiple Sclerosis and Related Disorders
Dobson R, Craner M, Waddingham E, Miller A, Cavey A, Webb S, Hemingway C, Hobart J et al. ( 2021 ) . Optimise: MS study protocol: A pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis . BMJ Open vol. 11 , ( 11 )
Geys L, Parciak T, Pirmani A, McBurney R, Schmidt H, Malbaša T, Ziemssen T, Bergmann A et al. ( 2021 ) . The Multiple Sclerosis Data Alliance Catalogue Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources . International Journal of MS Care vol. 23 , ( 6 ) 261 - 268 .
Dobson R, Baker D, Kang A, Schmierer K, Giovannoni G ( 2021 ) . COVID-19 vaccine response in people with multiple sclerosis . Annals of Neurology
Hone L, Jacobs B, Noyce A, Dobson R ( 2021 ) . Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 764 - 765 .
Stennett A, Allen-Philbey K, Begum T, Johnson A, Dobson R, Giovannoni G, Gnanapavan S, Marta M et al. ( 2021 ) . An evaluation of remote monitoring in people with MS during the COVID-19 pandemic . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 268 - 269 .
Bove R, Pasquarelli N, Borriello F, Dobson R, Hellwig K, McElrath T, Oreja-Guevara C, Wei W et al. ( 2021 ) . B-cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a phase 4 study (SOPRANINO) . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 583 - 584 .
Dobson R, Bove R, Borriello F, Craveiro L, Ferreira G, Hellwig K, McElrath T, Pasquarelli N et al. ( 2021 ) . Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 554 - 555 .
Ostrem B, Anderson A, Conway S, Oh J, Sadovnick D, Dobson R, Graham E, Jacobs D et al. ( 2021 ) . Pregnancy outcomes and peripartum disease activity in moderately and severely disabled women with MS . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 246 - 247 .
Hellwig K, Pasquarelli N, Borriello F, Bove R, Dobson R, Oreja-Guevara C, Vukusic S, Wei W et al. ( 2021 ) . Rationale and design of a phase 4 study exploring B-cell levels and immune responses in infants born to women with MS who were exposed to ocrelizumab up to 6 months before or during the first trimester of pregnancy (the MINORE study) . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 564 - 565 .
Vickaryous N, Asardag AN, Chance R, Jones M, Bestwick J, Shah SN, George K, Schmierer K et al. ( 2021 ) . Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy . MULTIPLE SCLEROSIS JOURNAL vol. 27 , ( 2_SUPPL ) 775 - 776 .
Simpson-Yap S, Pirmani A, De Brouwer E, Geys L, Parciak T, Helme A, Rijke N, Kalincik T et al. ( 2021 ) . Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 741 - 743 .
Hartmann M, Fenton N, Dobson R ( 2021 ) . Using Bayesian networks to understand multiple sclerosis risk factor interactions . MULTIPLE SCLEROSIS JOURNAL . vol. 27 , 375 - 375 .
Foote I, Jacobs B, Watson C, Bothongo P, Waters S, Dobson R, Noyce A, Bhui K et al. ( 2021 ) . W26. A MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF MODIFIABLE RISK FOR ALZHEIMER'S DISEASE: 269 LOCI ASSOCIATED WITH BRAIN HEALTH . European Neuropsychopharmacology vol. 51 , e159 - e159 .
Yam C, Rog D, Ford H, Murray K, Hughes S, Pearson O, Brex P, Dobson R ( 2021 ) . UK variance in DMT advice and prescribing in MS and pregnancy: impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines . Multiple Sclerosis and Related Disorders103272 - 103272 .
Kuri A, Jacobs BM, Leddy S, Schmierer K, Turner B, Allen-Philbey K, Stennett A, Giovannoni G et al. ( 2021 ) . Evaluation of remote assessments for multiple sclerosis in an in-home setting . Multiple Sclerosis and Related Disorders vol. 54 ,
Huxford B, Haque T, Joseph A, Simonet C, Gallagher D, Budu C, Dobson R, Noyce A ( 2021 ) . HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson's disease and type 2 diabetes . MOVEMENT DISORDERS . vol. 36 , S452 - S452 .
Jacobs BM, Noyce AJ, Bestwick J, Belete D, Giovannoni G, Dobson R ( 2021 ) . Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study . Neurology(R) neuroimmunology & neuroinflammation vol. 8 , ( 4 )
Jacobs BM, Smets I, Giovannoni G, Noyce A, Jokubaitis V, Dobson R ( 2021 ) . Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis . Multiple Sclerosis Journal vol. 27 , ( 8 ) 1311 - 1312 .
Dobson R ( 2021 ) . Differing Impact of DMT on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately? . Neurology
Leavitt VM, Dobson R, Svennigsson A ( 2021 ) . Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress . Neurology vol. 96 , ( 23 ) 1067 - 1068 .
Garjani A, Hunter R, Law G, Middleton R, Tuite-Dalton KA, Dobson R, Ford DV, Hughes S et al. ( 2021 ) . Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register . Multiple Sclerosis Journal
Dobson R, Hellwig K ( 2021 ) . Use of disease-modifying drugs during pregnancy and breastfeeding . Current Opinion in Neurology vol. 34 , ( 3 ) 303 - 311 .
Dobson R, ALLEN-PHILBEY K, Giovannoni G, Baker D, Schmierer K ( 2021 ) . Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis . Multiple Sclerosis and Related Disorders
Garjani A, Middleton RM, Hunter R, Tuite-Dalton KA, Coles A, Dobson R, Duddy M, Hughes S et al. ( 2021 ) . COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies . Multiple Sclerosis and Related Disorders vol. 52 , 102939 - 102939 .
Taylor TRP, Galloway J, Davies R, Hyrich K, Dobson R ( 2021 ) . Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis . Neurology(R) neuroimmunology & neuroinflammation vol. 8 , ( 3 )
Jensen MP, Jacobs BM, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Noyce AJ ( 2021 ) . Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease . Annals of Neurology vol. 89 , ( 4 ) 803 - 812 .
Krysko KM, Bove R, Dobson R, Jokubaitis V, Hellwig K ( 2021 ) . Treatment of Women with Multiple Sclerosis Planning Pregnancy . Current Treatment Options in Neurology vol. 23 , ( 4 )
Jitlal M, Amirthalingam G, Karania T, Parry E, Neligan A, Dobson R, Noyce A, MARSHALL C ( 2021 ) . The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017 . Journal of Alzheimer's Disease
Dobson R, Fenton N, Hartmann M ( 2021 ) . Current Review and Next Steps for Artificial intelligence in Multiple Sclerosis risk research . Computers in Biology and Medicine
Garjani A, Middleton R, Hunter R, Tuite-Dalton K, Coles A, Dobson R, Duddy M, Hughes S et al. ( 2021 ) . COVID-19 is associated with multiple sclerosis exacerbations that are prevented by disease modifying therapies .
Foote I, Jacobs B, Mathlin G, Watson C, Bothongo PLK, Waters S, Dobson R, Noyce A et al. ( 2021 ) . The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study .
Thomson A, Dobson R, Baker D, Giovannoni G ( 2021 ) . Digesting science: Developing educational activities about multiple sclerosis, prevention and treatment to increase the confidence of affected families . Multiple Sclerosis and Related Disorders vol. 47 ,
Evangelou N, Garjani A, Dasnair R, Hunter R, Tuite-Dalton KA, Craig EM, Rodgers WJ, Coles A et al. ( 2021 ) . Self-diagnosed COVID-19 in people with multiple sclerosis: A community-based cohort of the UK MS Register . Journal of Neurology, Neurosurgery and Psychiatry vol. 92 , ( 1 ) 107 - 109 .
Bothongo PL, Jitlal M, Parry E, Foote IF, Waters S, Dobson R, Noyce AJ, Bestwick JP et al. ( 2020 ) . Ethnic and socioeconomic determinants of dementia risk: A nested case‐control study in the population of East London . Alzheimer's & Dementia vol. 16 , ( S10 )
Garjani A, Hunter R, Nicholas R, Middleton R, Tuite-Dalton K, Coles A, Dobson R, Duddy M et al. ( 2020 ) . Anxiety affects the general well-being of people with ms during the COVID-19 pandemic more than the infection itself . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 65 - 65 .
Garjani A, Evangelou N, Das Nair R, Hunter R, Tuite-Dalton K, Coles A, Dobson R, Duddy M et al. ( 2020 ) . COVID-19 in people with MS: a large community-based study of the UK MS register . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 46 - 47 .
Taylor T, Luis J, Dobson R, Petrushkin H ( 2020 ) . Demographics of multiple sclerosis associated uveitis at moorfields eye hospital . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 484 - 484 .
Taylor T, Galloway J, Adam R, Hyrich K, Dobson R ( 2020 ) . Demyelinating events following initiation of anti-tnf alpha therapy in the british society for rheumatology biologics registry in rheumatoid arthritis . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 241 - 241 .
Jacobs B, Noyce A, Bestwick J, Belete D, Giovannoni G, Dobson R ( 2020 ) . Gene-environment interactions in multiple sclerosis: a uk biobank study . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 367 - 367 .
Vickaryous N, Jitlal M, Jacobs BM, Middleton R, Chandran S, MacDougall NJJ, Giovannoni G, Dobson R ( 2020 ) . Remote testing of vitamin D levels across the UK MS population—A case control study . PLoS ONE vol. 15 , ( 12 December )
Vickaryous N, Garjani A, Jacobs B, Jitlal M, Middleton R, Das Nair R, Tuite-Dalton K, Hunter R et al. ( 2020 ) . Vitamin D levels in the UK MS population and COVID-19 susceptibility . MULTIPLE SCLEROSIS JOURNAL . vol. 26 , 55 - 55 .
Vickaryous N, Jitlal M, Jacobs BM, Middleton R, Chandran S, MacDougall NJJ, Giovannoni G, Dobson R ( 2020 ) . Remote testing of vitamin D levels across the UK MS population – a case control study .
Auger SD, Jacobs BM, Dobson R, Marshall CR, Noyce AJ ( 2020 ) . Big data, machine learning and artificial intelligence: a neurologist's guide . Pract Neurol
Auger S, Jacobs B, Dobson R, MARSHALL C, Noyce A ( 2020 ) . Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide . Practical Neurology
Jacobs B, Belete D, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, International Parkinson’s Disease Genomics Consortium (IPDGC) et al. ( 2020 ) . Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank . Journal of Neurology, Neurosurgery and Psychiatry vol. 91 , 1046 - 1054 .
Leddy S, Dobson R ( 2020 ) . Multiple sclerosis . Medicine (United Kingdom) vol. 48 , ( 9 ) 588 - 594 .
Belete D, Jacobs B, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls M et al. ( 2020 ) . Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank . MOVEMENT DISORDERS . vol. 35 , S74 - S74 .
Dobson R, Giovannoni G, Cuzick J ( 2020 ) . Estimated and projected burden of multiple sclerosis attributable to smoking and childhood and adolescent high body-mass index: a comparative risk assessment . International Journal of Epidemiology
Dobson R ( 2020 ) . MS, pregnancy and COVID-19 . Multiple Sclerosis Journal
Jacobs B, Taylor T, Awad A, Baker D, Giovannoni G, Noyce A, Dobson R ( 2020 ) . Summary-data-based mendelian randomisation prioritises potential druggable targets for Multiple Sclerosis . Brain Communications
Taylor TR, Jacobs BM, Giovannoni G, Petrushkin H, Dobson R ( 2020 ) . Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study . Multiple Sclerosis and Related Disorders vol. 43 ,
Peeters LM, Parciak T, Walton C, Geys L, Moreau Y, De Brouwer E, Raimondi D, Pirmani A et al. ( 2020 ) . COVID-19 in people with multiple sclerosis: A global data sharing initiative . Mult Scler1352458520941485 - 1352458520941485 .
Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J et al. ( 2020 ) . Protecting people with multiple sclerosis through vaccination . Practical Neurology
Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R et al. ( 2020 ) . Sex effects across the lifespan in women with multiple sclerosis . Therapeutic Advances in Neurological Disorders vol. 13 ,
Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middeldorp J, Giovannoni G, Dobson R ( 2020 ) . Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom . BMC Public Health vol. 20 , ( 1 )
Dobson R, Jokubaitis V, Giovannoni G ( 2020 ) . Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis . Multiple Sclerosis and Related Disorders
Dobson R, Mowry EM ( 2020 ) . Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis . Neurology vol. 94 , ( 18 ) 769 - 770 .
Leddy S, Jacobs BM, Giovannoni G, Dobson R ( 2020 ) . To examine the impact of Multiple Sclerosis on bone health and explore mechanisms for this association . EUROPEAN JOURNAL OF NEUROLOGY . vol. 27 , 981 - 981 .
Leddy S, Jacobs B, Giovannoni G, Dobson R ( 2020 ) . Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study . NEUROLOGY . vol. 94 ,
Jacobs B, Giovannoni G, Dobson R ( 2020 ) . Environmental exposures associated with Multiple Sclerosis: a UK Biobank study . NEUROLOGY . vol. 94 ,
Dobson R, Jitlal M, Marshall CR, Noyce AJ, Robson J, Cuzick J, Giovannoni G ( 2020 ) . Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk . Annals of Neurology vol. 87 , ( 4 ) 599 - 608 .
Dobson R, Jacobs B, Giovannoni G, Cuzick J ( 2020 ) . Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors . Multiple Sclerosis Journal
Jokubaitis VG, Dobson R ( 2020 ) . Reader response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis . Neurology vol. 94 , ( 10 ) 455 - 456 .
Jokubaitis V, Dobson R ( 2020 ) . Family planning is the second most relevant factor for treatment decisions after disease activity . Multiple Sclerosis Journal
Dobson R, Noyce A, Giovannoni G, jacobs B ( 2020 ) . BMI and low serum vitamin D are causal risk factors for Multiple Sclerosis: a Mendelian Randomisation study . Neurology, Neuroimmunology and Neuroinflammation
Jacobs BM, Giovannoni G, Cuzick J, Dobson R ( 2019 ) . Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors . medRxiv19007450 - 19007450 .
Dobson R, Jitlal M, Marshall C, Noyce A, Giovannoni G ( 2019 ) . Obesity is not associated with MS in a socially and ethnically diverse population . MULTIPLE SCLEROSIS JOURNAL . vol. 25 , 49 - 49 .
Vickaryous N, Jitlal M, Middleton R, Giovannoni G, Dobson R ( 2019 ) . Vitamin D levels in the UK MS population . MULTIPLE SCLEROSIS JOURNAL . vol. 25 , 449 - 450 .
DOBSON R ( 2019 ) . Visibility and representation of women in multiple sclerosis research . Neurology
Dobson R, Dassan P, Roberts M, Giovannoni G, Nelson-Piercy C, Brex PA ( 2019 ) . UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines . Pract Neurol
Waubant E, Amezcua L, Sicotte N, Hellwig K, Krupp L, Weinstock-Guttman B, Yeh A, Lucas RM et al. ( 2018 ) . Gender Inequities in the Multiple Sclerosis Community: A Call for Action . Annals of Neurology vol. 84 , ( 6 ) 958 - 959 .
Dobson R ( 2018 ) . Clinical commentary on 'Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a note of caution' . Mult Scler1352458518807053 - 1352458518807053 .
Dobson R, Giovannoni G ( 2018 ) . Multiple Sclerosis - a review . Eur J Neurol vol. 26 , 27 - 40 .
Thomson A, Aldam R, Giovannoni G, Dobson R ( 2018 ) . Making science digestible: the development of educational activities for children with a parent with MS, and the need to better engage families . MULTIPLE SCLEROSIS JOURNAL . vol. 24 , 972 - 972 .
Dobson R, Cock HR, Brex P, Giovannoni G ( 2018 ) . Vitamin D supplementation . Practical Neurology vol. 18 , ( 1 ) 35 - 42 .
Middleton RM, Rodgers WJ, Giovannoni G, Schmierer K, Dobson R, Allen-Philbey K, Patterson A, Akbari A et al. ( 2017 ) . A Comparison of participant supplied EDSS scores and clinically submitted data via the UK MS Register . MULTIPLE SCLEROSIS JOURNAL . vol. 23 , 153 - 154 .
Dobson R, Kuhle J, Middeldorp J, Giovannoni G ( 2017 ) . Epstein-Barr-negative MS: a true phenomenon? . Neurol Neuroimmunol Neuroinflamm vol. 4 , ( 2 ) e318 - e318 .
Dobson R, Ramagopalan S, Topping J, Smith P, Solanky B, Schmierer K, Chard D, Giovannoni G ( 2016 ) . A Risk Score for Predicting Multiple Sclerosis . PLoS One vol. 11 , ( 11 ) Article 0164992 , e0164992 - e0164992 .
Collins CDE, Ivry B, Bowen JD, Cheng EM, Dobson R, Goodin DS, Lechner-Scott J, Kappos L et al. ( 2016 ) . A comparative analysis of Patient-Reported Expanded Disability Status Scale tools . Multiple Sclerosis vol. 22 , ( 10 ) 1349 - 1358 .
Binks S, Dobson R ( 2016 ) . Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease . Curr Osteoporos Rep vol. 14 , ( 5 ) 199 - 210 .
Dobson R, Alvares D ( 2016 ) . The difficulties with vitamin B<inf>12</inf> . Practical Neurology vol. 16 , ( 4 ) 308 - 311 .
Topping J, Dobson R, Lapin S, Maslyanskiy A, Kropshofer H, Leppert D, Giovannoni G, Evdoshenko E ( 2016 ) . The effects of intrathecal rituximab on biomarkers in multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 6 , 49 - 53 .
Davis AG, Dobson R, Kaninia S, Giovannoni G, Schmierer K ( 2016 ) . Atraumatic needles for lumbar puncture: Why haven’t neurologists changed? . Practical Neurology vol. 16 , ( 1 ) 18 - 22 .
Disanto G, Adiutori R, Dobson R, Martinelli V, Costa GD, Runia T, Evdoshenko E, Thouvenot E et al. ( 2016 ) . Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome . Journal of Neurology, Neurosurgery and Psychiatry vol. 87 , ( 2 ) 126 - 129 .
Binks S, Dobson R ( 2015 ) . Established, new and future disease modifying therapies for MS . Progress in Neurology and Psychiatry vol. 19 , ( 5 ) 27 - 35 .
Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu CH, Dobson R et al. ( 2015 ) . Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome . Journal of Neurology, Neurosurgery and Psychiatry vol. 86 , ( 3 ) 273 - 279 .
Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu C-H, Dobson R et al. ( 2015 ) . Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome . J Neurol Neurosurg Psychiatry vol. 86 , ( 3 ) 273 - 279 .
Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC et al. ( 2015 ) . Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study . Multiple Sclerosis Journal vol. 21 , ( 8 ) 1013 - 1024 .
Leddy S, Fowler AJ, Giovanonni G, Dobson R ( 2014 ) . DEPRESSION IN MS: A SYSTEMATIC REVIEW AND META-ANALYSIS . Journal of Neurology Neurosurgery & Psychiatry . vol. 85 , e4 - e4 .
Cooper R, Doshi A, Harris P, Sivagnanasundaram J, Wells G, Barritt A, Aram J, Giovannoni G et al. ( 2014 ) . IMMUNOCOMPETENT PML—AN IMMUNOLOGICAL SCOTOMA? . Journal of Neurology Neurosurgery & Psychiatry . vol. 85 , e4 - e4 .
Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Gobbi C, Kuhle J, Giovannoni G ( 2014 ) . Genetic predictors of multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 20 , 253 - 253 .
Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Kuhle J, Giovannoni G ( 2014 ) . The refinement of genetic predictors of multiple sclerosis . PLoS ONE vol. 9 , ( 5 )
Shribman SE, Torsney K, Noyce AJ, Giovannoni G, Fearnley J, Dobson R ( 2014 ) . A service development study of the assessment and management of fracture risk in Parkinson's disease . MOVEMENT DISORDERS . vol. 29 , S192 - S192 .
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . A systematic review and meta-analysis of fracture risk in Parkinson's disease . MOVEMENT DISORDERS . vol. 29 , S551 - S551 .
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . Bone health in Parkinson's disease: A systematic review and meta-analysis . MOVEMENT DISORDERS . vol. 29 , S551 - S551 .
Davis A, Dobson R, Kaninia S, Espasandin M, Berg A, Giovannoni G, Schmierer K ( 2014 ) . Change practice now! Using atraumatic needles to prevent post lumbar puncture headache . European Journal of Neurology vol. 21 , ( 2 ) 305 - 311 .
Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G ( 2014 ) . Assessing treatment response to interferon-beta Is there a role for MRI? . NEUROLOGY vol. 82 , ( 3 ) 248 - 254 .
Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G ( 2014 ) . Assessing treatment response to interferon-β :Is there a role for MRI? . Neurology vol. 82 , ( 3 ) 248 - 254 .
Shribman S, Torsney KM, Noyce AJ, Giovannoni G, Fearnley J, Dobson R ( 2014 ) . A service development study of the assessment and management of fracture risk in Parkinson's disease . Journal of Neurology vol. 261 , ( 6 ) 1153 - 1159 .
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ ( 2014 ) . Bone health in Parkinson's disease: A systematic review and meta-analysis . Journal of Neurology, Neurosurgery and Psychiatry vol. 85 , ( 10 ) 1159 - 1166 .
Raffel J, Dobson R, Gafson A, Mattoscio M, Muraro P, Giovannoni G ( 2014 ) . Multiple sclerosis therapy and Epstein-Barr virus antibody titres . Multiple Sclerosis and Related Disorders vol. 3 , ( 3 ) 372 - 374 .
Hadavi S, Baker MD, Dobson R ( 2014 ) . Sustained-release fampridine in Multiple Sclerosis . Multiple Sclerosis and Related Disorders vol. 3 , ( 1 ) 17 - 21 .
Leddy S, Hadavi S, Carren AM, Giovanonni G, Dobson R ( 2013 ) . A novel internet-based method of capturing outcomes in multiple sclerosis . J Neurol Neurosurg Psychiatry vol. 84 , ( 11 )
Hadavi S, Giovannoni G, Dobson R ( 2013 ) . A service development audit of fampridine use in ms . J Neurol Neurosurg Psychiatry vol. 84 , ( 11 )
Dobson R, Topping J, Davis A, Thompson E, Giovannoni G ( 2013 ) . Cerebrospinal fluid and urinary biomarkers in multiple sclerosis . Acta Neurologica Scandinavica vol. 128 , ( 5 ) 321 - 327 .
Hadavi S, Shribman S, Nagy A, Acharya S, Fearnley J, Dobson R, Lees A, Giovannoni G et al. ( 2013 ) . The bradykinesia-akinesia incoordination test: a simple objective test in multiple sclerosis . J Neurol Neurosurg Psychiatry vol. 84 , ( 11 )
Dobson R, McMillan A, Kung K, Thom M, Davis A, Simister R, Giovannoni G, Gnanapavan S ( 2013 ) . Think outside the box, collapse the box, and take a sharp knife to it! . J Neurol Neurosurg Psychiatry vol. 84 , ( 11 )
Dobson R, Topping J, Ramagopalan S, Giovannoni G ( 2013 ) . Towards an endophenotype in multiple sclerosis . J Neurol Neurosurg Psychiatry vol. 84 , ( 11 )
Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R ( 2013 ) . A novel internet-based method of capturing outcomes in multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 19 , 357 - 358 .
Dobson R, Giovannoni G ( 2013 ) . Bone health in multiple sclerosis: should we be doing more? . Neurodegenerative Disease Management vol. 3 , ( 5 ) 401 - 403 .
Kuhle J, Dobson R, Bestwick JP, Topping J, Dalla Costa G, Khademi M, Sombekke M, Killestein J et al. ( 2013 ) . Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS . MULTIPLE SCLEROSIS JOURNAL . vol. 19 , 33 - 34 .
James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV ( 2013 ) . The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis . Mult Scler vol. 19 , ( 12 ) 1571 - 1579 .
Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R ( 2013 ) . Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis . J Neurol vol. 260 , ( 10 ) 2505 - 2510 .
Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU et al. ( 2013 ) . Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases . PLoS ONE vol. 8 , ( 9 )
Dobson R, Ramagopalan S, Davis A, Giovannoni G ( 2013 ) . Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude . J Neurol Neurosurg Psychiatry vol. 84 , ( 8 ) 909 - 914 .
Dobson R, Giovannoni G ( 2013 ) . Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis . J Neurol vol. 260 , ( 5 ) 1272 - 1285 .
Dobson R, Yarnall A, Noyce AJ, Giovannoni G ( 2013 ) . Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes . Pract Neurol vol. 13 , ( 2 ) 70 - 79 .
Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV ( 2013 ) . Correction: Meta-analysis of the relationship between multiple sclerosis and migraine (PLoS ONE) . PLoS ONE vol. 8 , ( 4 )
Dobson R, Giovannoni G, Ramagopalan S ( 2013 ) . The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude . J Neurol Neurosurg Psychiatry vol. 84 , ( 4 ) 427 - 432 .
Dobson R, Leddy SG, Gangadharan S, Giovannoni G ( 2013 ) . Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems . BMJ Open vol. 3 , ( 3 )
Dobson R, Ramagopalan SV, Giovannoni G ( 2013 ) . Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics? . Expert Rev Neurother vol. 13 , ( 3 ) 235 - 237 .
Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, Ramagopalan SV ( 2013 ) . The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis . Mult Scler vol. 19 , ( 2 ) 162 - 166 .
Dobson R, Ramagopalan S, Davis A, Giovannoni G ( 2013 ) . Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude . Journal of Neurology, Neurosurgery and Psychiatry vol. 84 , ( 8 ) 909 - 914 .
Dobson R, Topping J, Giovannoni G ( 2013 ) . Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers . J Med Virol vol. 85 , ( 1 ) 128 - 131 .
Evdoshenko E, Maslyanskiy A, Lapin S, Zaslavsky L, Dobson R, Totolian A, Skoromets A, Bar-Or A ( 2013 ) . Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone . ISRN Neurol vol. 2013 ,
Dobson R, Giovannoni G, Ramagopalan S ( 2013 ) . The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude . Journal of Neurology, Neurosurgery and Psychiatry vol. 84 , ( 4 ) 427 - 432 .
Dobson R, Ramagopalan S, Giovannoni G ( 2012 ) . Bone health and multiple sclerosis . Mult Scler vol. 18 , ( 11 ) 1522 - 1528 .
Dobson R, Rudick RA, Giovannoni G ( 2012 ) . CAN WE RELIABLY USE MRI TO MONITOR TREATMENT RESPONSE IN PATIENTS ON INTERFERON beta: A SYSTEMATIC REVIEW AND META-ANALYSIS . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,
Dobson R, Ramagopalan S, Giovannoni G ( 2012 ) . Risk of fractures in patients with multiple sclerosis: A populationbased cohort study . Neurology vol. 79 , ( 18 ) 1934 - 1935 .
Davis A, Dobson R, Espasandin M, Giovannoni G, Schmierer K ( 2012 ) . Cerebrospinal fluid biomarkers as outcome measures in clinical trials of MS: The significance of post lumbar puncture headaches . MULTIPLE SCLEROSIS JOURNAL . vol. 18 , 237 - 238 .
Dobson R, Ramagopalan S, Giovannoni G ( 2012 ) . Osteoporosis and fracture risk in multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 18 , 243 - 244 .
Topping J, Evdoshenko E, Dobson R, Lapin S, Maslyanskiy A, Giovannoni G ( 2012 ) . The effects of intrathecal rituximab on biomarkers in MS . MULTIPLE SCLEROSIS JOURNAL . vol. 18 , 268 - 268 .
Dobson R, Topping J, Davis A, Giovannoni G ( 2012 ) . Urinary and CSF biomarkers in multiple sclerosis . MULTIPLE SCLEROSIS JOURNAL . vol. 18 , 502 - 503 .
Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV ( 2012 ) . Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine . PLoS ONE vol. 7 , ( 9 )
Dobson R, Ramagopalan S, Giovannoni G ( 2012 ) . The effect of gender in clinically isolated syndrome (CIS): a meta-analysis . Mult Scler vol. 18 , ( 5 ) 600 - 604 .
Dobson R ( 2012 ) . Urine: An under-studied source of biomarkers in multiple sclerosis? . Multiple Sclerosis and Related Disorders vol. 1 , ( 2 ) 76 - 80 .
Disanto G, Sandve GK, Berlanga-Taylor AJ, Morahan JM, Dobson R, Giovannoni G, Ramagopalan SV ( 2012 ) . Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells . PLOS ONE vol. 7 , ( 3 ) Article ARTN e32281 ,
Dobson R, Meier UC, Schmierer K, Giovannoni G ( 2012 ) . DO SIBLINGS OF PEOPLE WITH MULTIPLE SCLEROSIS (MS) HAVE MARKERS OF MS RISK? . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,
Raffel J, Dobson R, Giovannoni G ( 2012 ) . THE EFFECT OF NATALIZUMAB AND INTERFERON-beta ON URINARY FREE LIGHT CHAINS AND ANTI-EBV NUCLEAR ANTIGEN-1 ANTIBODIES IN RELAPSING REMITTING MULTIPLE SCLEROSIS . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,
Dobson R, Giovannoni G ( 2012 ) . WHY CAN'T I WIN ANY MORE? . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 83 ,
Dobson R, Meier UC, Marta M, Ramagopalan S, Giovannoni G ( 2011 ) . Vitamin D deficiency - do we follow our own advice? . CLINICAL MEDICINE vol. 11 , ( 6 ) 521 - 523 .
Dobson R, Meier UC, Schmierer K, Giovannoni G ( 2011 ) . Do siblings have markers of multiple sclerosis risk? . MULTIPLE SCLEROSIS JOURNAL vol. 17 , S86 - S86 .
Dobson R, Lawden M ( 2011 ) . Melanoma associated retinopathy and how to understand the electroretinogram . Pract Neurol vol. 11 , ( 4 ) 234 - 239 .
Maghzi A-H, Marta M, Bosca I, Etemadifar M, Dobson R, Maggiore C, Giovannoni G, Meier U-C ( 2011 ) . Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection? . Pathophysiology vol. 18 , ( 1 ) 13 - 20 .
Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV ( 2011 ) . Smoking and Multiple Sclerosis: An Updated Meta-Analysis . PLOS ONE vol. 6 , ( 1 ) Article e16149 ,
Meier UC, Giovannoni G ( 2011 ) . More to come: humoral immune responses in MS . Journal of Neuroimmunology vol. 240-241 , 13 - 21 .
Dobson R, Feldmann M, Thompson AJ, Giovannoni G, Miller DH, Thompson EJ, Palmer HE, Miller RF ( 2010 ) . INCREASED URINARY FREE IMMUNOGLOBULIN LIGHT CHAIN EXCRETION IN PATIENTS WITH MULTIPLE SCLEROSIS . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY . vol. 81 , E57 - E57 .
Dobson R, Lawden M ( 2010 ) . CP1 Darkness visible . Journal of Neurology Neurosurgery & Psychiatry vol. 81 , ( 11 )
Ramagopalan SV, Dobson R, Meier UC, Giovannoni G ( 2010 ) . Multiple sclerosis: risk factors, prodromes, and potential causal pathways . Lancet Neurol vol. 9 , ( 7 ) 727 - 739 .
Dobson R, Miller RF, Palmer HE, Feldmann M, Thompson EJ, Thompson AJ, Miller DH, Giovannoni G ( 2010 ) . Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis . J Neuroimmunol vol. 220 , ( 1-2 ) 99 - 103 .